Open access
Sep 2026
651. Moderate cannabidiol (CBD) with low dose delta-9-tetrahydrocannabinol (THC) combined formulation for chronic pain and related symptoms
Abstract Background Cannabis-based compounds as therapeutics for various pain-related illnesses are being explored. However, uncertainty remains regarding effective formulations for specific symptoms, optimal dosing of specific cannabinoids and the risk of misuse. This project previously evaluated specific CBD and CBD+...
R. Sinha, E. Sakmar, N. Fogelman et al.
· International Journal of Neu... · 0 citations